What Are Viruses? Structure, Replication, Classification, and How They Cause Disease

What Is a Virus?

A virus is an infectious agent so small it can only be visualized with an electron microscope — typically 20–300 nanometers in diameter, roughly 100 times smaller than most bacteria. Unlike bacteria, fungi, or parasites, viruses are not cells. They have no metabolism of their own, no ribosomes, no ability to generate energy or synthesize proteins independently. They are, in the strictest biological sense, obligate intracellular parasites: entities that can only replicate by hijacking the molecular machinery of living host cells.

Whether viruses are "alive" is a genuine philosophical question in biology. They are not alive outside of cells (they cannot reproduce, respond to stimuli, or maintain homeostasis), but inside cells they display the defining property of life: self-replication with heritable variation subject to natural selection. This ambiguity makes them uniquely interesting and uniquely challenging to combat.

Viral Structure

All viruses share two fundamental components:

1. Genetic material: Either DNA or RNA (never both), encoding the instructions the virus needs the host cell to execute for replication. The genome can be single- or double-stranded, linear or circular, segmented (influenza has 8 RNA segments) or unsegmented.
2. Capsid: A protein coat made of repeating protein subunits (capsomeres) that encases and protects the genetic material. Capsids adopt specific geometric shapes: icosahedral (soccer-ball-like, e.g., adenovirus), helical (rod-like, e.g., tobacco mosaic virus), or complex (e.g., bacteriophages).

Many animal viruses additionally have a lipid envelope — a membrane derived from the host cell's own membrane, studded with viral glycoproteins that facilitate attachment to new host cells. Enveloped viruses (influenza, HIV, SARS-CoV-2, Ebola) are generally more sensitive to disinfectants and detergents (soap disrupts lipid membranes) than non-enveloped viruses (norovirus, poliovirus).

The Viral Replication Cycle

Viral replication follows a conserved sequence of steps:

1. Attachment: Viral surface proteins bind to specific receptor molecules on the host cell surface. This receptor specificity determines host range — SARS-CoV-2's spike protein binds ACE2 receptors, abundant in respiratory and GI epithelium. HIV's gp120 protein binds CD4 receptors on T-helper lymphocytes.
2. Entry: The virus or its genetic material enters the cell, either by membrane fusion (enveloped viruses) or endocytosis.
3. Uncoating: The capsid is disassembled, releasing the viral genome inside the cell.
4. Replication and transcription: The viral genome is replicated using host or viral polymerases; viral mRNA is produced and translated into viral proteins using host ribosomes.
5. Assembly: New viral particles are assembled from newly synthesized genomes and capsid proteins.
6. Release: New virions exit the cell by budding (enveloped viruses, which acquire their envelope from the host membrane) or cell lysis (non-enveloped viruses, which burst the host cell).

The entire cycle can take as little as 6–8 hours. A single infected cell can release hundreds to thousands of new viral particles.

DNA vs. RNA Viruses

RNA viruses mutate far more rapidly than DNA viruses because RNA-dependent RNA polymerases (RdRp) lack the proofreading activity of DNA polymerases — introducing roughly 1 error per 10,000 nucleotides copied, vs. ~1 per billion for DNA polymerases. This high mutation rate enables rapid evolution and immune escape (why flu vaccines must be updated annually) but also creates large populations of defective variants.

HIV uses a special enzyme called reverse transcriptase to convert its RNA genome into DNA, which is then integrated into the host cell's chromosome — making it especially difficult to eradicate, as the viral DNA persists even in non-replicating cells.

How Viruses Cause Disease

Viral pathology arises through multiple mechanisms:

• Direct cytopathic effects: Cell lysis, induction of apoptosis (programmed cell death), or interference with cell function. Poliovirus destroys motor neurons; HIV depletes CD4 T cells.
• Immune-mediated damage: The immune response itself causes tissue damage. Much of the severe pathology in COVID-19, dengue, and influenza results from hyperactivation of the immune system (cytokine storms) rather than direct viral killing.
• Oncogenic transformation: Some viruses (HPV, EBV, hepatitis B and C) integrate their DNA or dysregulate cellular control genes, driving cancer development. Approximately 15–20% of all human cancers are virus-associated.
• Immunosuppression: HIV destroys the immune system over years, leaving the host vulnerable to opportunistic infections.

Antiviral Strategies

Unlike antibiotics (which target bacterial structures absent in human cells), antivirals must target viral-specific processes without harming host cells — a much harder design challenge:

• Nucleoside analogs (acyclovir for herpes, sofosbuvir for hepatitis C, remdesivir for COVID-19): Mimic viral nucleotides to block viral polymerases
• Protease inhibitors (HIV antiretrovirals): Block viral proteases needed to process viral proteins
• Neuraminidase inhibitors (oseltamivir/Tamiflu): Block influenza surface enzyme needed for viral release
• Monoclonal antibodies (Paxlovid, bebtelovimab): Bind and neutralize specific viral proteins

Vaccines — by training the immune system to recognize viral antigens before infection — remain the most effective tool against viruses. The mRNA vaccines against COVID-19 (Pfizer-BioNTech and Moderna), authorized in late 2020, demonstrated 90–95% efficacy in clinical trials and represented the first licensed mRNA vaccines in history, validated after decades of prior research on the platform.